Protein structure-based protein language models
AssigneesIllumina, Inc., Illumina Cambridge Limited
InventorsTobias Hamp, Hong Gao, Kai-How Farh
Life of this patent
Estimating the term…
Loading patent…
AssigneesIllumina, Inc., Illumina Cambridge Limited
InventorsTobias Hamp, Hong Gao, Kai-How Farh
Estimating the term…
The technology disclosed relates to determining pathogenicity of nucleotide variants. In particular, the technology disclosed relates to specifying a particular amino acid at a particular position in a protein as a gap amino acid, and specifying remaining amino acids at remaining positions in the protein as non-gap amino acids. The technology disclosed further relates to generating a gapped spatial representation of the protein that includes spatial configurations of the non-gap amino acids, and excludes a spatial configuration of the gap amino acid, and determining a pathogenicity of a nucleotide variant based at least in part on the gapped spatial representation, and a representation of an alternate amino acid created by the nucleotide variant at the particular position.
A computer-implemented method of scoring nucleotide variants as benign or pathogenic, including:
A non-transitory computer readable storage medium impressed with computer program instructions to score nucleotide variants as benign or pathogenic, the instructions, when executed on a processor, implement a method comprising:
A system including one or more processors coupled to memory, the memory loaded with computer instructions to score nucleotide variants as benign or pathogenic, the computer instructions, when executed on the one or more processors, implement actions comprising:
Dependencies are inferred from the claim text.